Colorectal Adenoma Characteristics, as Predictors of Recurrence

Diseases of the Colon and Rectum

Volumn 47, Issue 3, 2004, Pages 323-333

  Bonithon Kopp, C ^a   Piard, F ^a   Fenger, C ^b   Cabeza, E ^c   O'Morain, C ^d   Kronborg, O ^b   Faivre, J ^a  

^a INSERM   (France)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITAT DE LES ILLES BALEARS   (Spain)

^d Gastroenterology Center   (Ireland)

Author keywords

Colon site; Colorectal adenoma; Histology; Recurrence

Indexed keywords

ADENOMA; ADULT; AGED; ARTICLE; ASCENDING COLON; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL TUMOR; DESCENDING COLON; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; TUMOR RECURRENCE;

ADENOMA; COLON; COLONOSCOPY; COLORECTAL NEOPLASMS; DOUBLE-BLIND METHOD; EUROPE; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; RISK FACTORS;

EID: 1442275283     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10350-003-0054-1     Document Type: Article

References (36)

1. Eide TJ, Stalsberg H. Polyps of the large intestine in Northern Norway. Cancer 1978;42:2839-48.
2. Rickert RR, Auerbach O, Garfinkel L, Hammond EC, Frasca JM. Adenomatous polyps of the large bowel. An autopsy study. Cancer 1979;43:1847-57.
3. Vatn MH, Stalsberg H. The prevalence of polyps of the large intestine in Oslo: an autopsy study. Cancer 1982;49:819-25.
4. Michiels C, Faivre J, Milan C, Hillon P, Klepping C. Prévalence des adénomes rectocoliques: résultats d'une série autopsique en Côte d'Or. Gastroenterol Clin Biol 1990;14:A52.
5. Eide TJ. Natural history of adenoma. World J Surg 1991;15:3-6.
6. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1742-77.
7. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996;348:1467-71.
8. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993;328:1365-71.
9. Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 1993;329:1977-81.
10. Jorgensen OD, Kronborg O, Fenger C. The Funen adenoma follow-up study. Incidence and death from colorectal carcinoma in an adenoma surveillance program. Scand J Gastroenterol 1993;28:869-74.
11. Citarda F, Tomaselli G, Capocaccia R, Barcherini S, Crespi M, the Multicentre Study Group. Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence. Gut 2001;48:812-5.
12. Van Stolk RU, Beck GJ, Baron JA, Haile R, Summers R, for the Polyp Prevention Study Group. Adenoma characteristics at first colonoscopy as predictors of adenoma recurrence and characteristics at follow-up. Gastroenterology 1998;115:13-8.
13. Martinez ME, Sampliner R, Marshall JR, Bhattacharyya AK, Reid ME, Alberts DS. Adenoma characteristics as risk factors for recurrence of advanced adenomas. Gastroenterology 2000;120:1077-83.
14. Faivre J, Couillault C, Kronborg O, et al. Chemoprevention of metachronous adenomas of the large bowel: design and interim results of a randomised trial of calcium and fibre. Eur J Cancer Prev 1997;6:132-8.
15. Bonithon-Kopp C, Kronborg O, Giacosa A, Räth U, Faivre J, for the European Cancer Prevention Organisation Study Group. Calcium and fibre supplementation in prevention of colorectal adenoma recurrence: a randomised intervention trial. Lancet 2000;356:1300-6.
16. O'Brien MJ, Winawer SJ, Zauber AG, et al. The National Polyp study. Patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomas. Gastroenterology 1990;98:371-9.
17. Matek W, Guggenmoos-Holzmann I, Demling L. Follow-up of patients with colorectal adenomas. Endoscopy 1985;17:175-81.
18. Kellokumpu I, Husa A. Colorectal adenomas: morphologic features and the risk of developing metachronous adenomas and carcinomas in the colorectum. Scand J Gastroenterol 1987;22:833-41.
19. Winawer SJ, Zauber AG, O'Brien MJ, et al. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. N Engl J Med 1993;328:901-6.
20. Neugut AI, Jacobson JS, Ahsan H, et al. Incidence and recurrence rates of colorectal adenomas: a prospective study. Gastroenterology 1995;108:402-8.
21. Fornasarig M, Valentini M, Poletti M, et al. Evaluation of the risk of metachronous colorectal neoplasms following intestinal polypectomy: a clinical, endoscopic and pathological study. Hepatogastroenterology 1998;45:1565-72.
22. Yang G, Zheng W, Sun QR, et al. Pathologic features of initial adenomas as predictors for metachronous adenomas of the rectum. J Natl Cancer Inst 1998;90:1661-5.
23. Noshirwani KC, van Stolk RU, Rybicki LA, Beck GJ. Adenoma size and number are predictive of adenoma recurrence: implications for surveillance colonoscopy. Gastrointest Endosc 2000;51:433-7.
24. Avidan B, Sonnenberg A, Schnell TG, Leya J, Metz A, Sontag SJ. New occurrence and recurrence of neoplasms within 5 years of a screening colonoscopy. Am J Gastroenterol 2002;97:1524-9.
25. Henry LG, Condon RE, Schulte WJ, Aprahamian C, De-Cosse JJ. Risk of recurrence of colon polyps. Ann Surg 1975;182:511-5.
26. Hixson LJ, Fennerty MB, Sampliner RE, McGee D, Garewal H. Prospective study of the frequency and size distribution of polyps missed by colonoscopy. J Natl Cancer Inst 1990;82:1769-72.
27. Rex DK, Cutler CS, Lemmel GT, et al. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology 1997;112:24-8.
28. Eide TJ. Risk of colorectal cancer in adenoma-bearing individual within a defined population. Int J Cancer 1986;38:173-6.
29. Simons BD, Morrison AS, Lev R, Verhock-Oftedahl W. Relationship of polyps to cancer of the large intestine. J Natl Cancer Inst 1992;84:962-6.
30. Atkin WS, Morson BC, Cuzick J. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med 1992;326:658-62.
31. Lynch HT, Smyrk TC, Watson P, et al. Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology 1993;104:1535-49.
32. Faivre J, Bedenne L, Boutron MC, Collonges R. Epidemiological evidence for distinguishing subsites of colorectal cancers. J Epidemiol Comm Health 1989;43:356-61.
33. Bonithon-Kopp C, Benhamiche AM. Are there several colorectal cancers? Epidemiological data. Eur J Cancer Prev 1999;8(Suppl 1):S3-12.
34. Toyota M, Ohe-Toyota M, Ahuja M, Issa JP. Distinct genetic profiles in colorectal tumors with and without the CpG island methylator phenotype. Proc Natl Acad Sci U S A 2000;97:710-5.
35. Halford SE, Rowan AJ, Lipton L, et al. Germline mutations but not somatic changes at the MYH locus contribute to the pathogenesis of unselected colorectal cancers. Am J Pathol 2003;162:1545-8.
36. Sieber OM, Lipton L, Crabtree M, et al. Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. N Engl J Med 2003;348:845-7.